$911 Million is the total value of Rhenman & Partners Asset Management AB's 88 reported holdings in Q1 2023. The portfolio turnover from Q4 2022 to Q1 2023 was 100.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| NKTR | Exit | NEKTAR THERAPEUTICS | $0 | – | -550,000 | -100.0% | -0.13% | – |
| IONS | Exit | IONIS PHARMACEUTICALS INC | $0 | – | -50,000 | -100.0% | -0.20% | – |
| GTHX | Exit | G1 THERAPEUTICS INC | $0 | – | -370,000 | -100.0% | -0.21% | – |
| PHAT | Exit | PHATHOM PHARMACEUTICALS INC | $0 | – | -235,210 | -100.0% | -0.28% | – |
| TDOC | Exit | TELADOC HEALTH INC | $0 | – | -130,000 | -100.0% | -0.32% | – |
| OSH | Exit | OAK STR HEALTH INC | $0 | – | -250,000 | -100.0% | -0.56% | – |
| NVST | Exit | ENVISTA HOLDINGS CORPORATION | $0 | – | -163,800 | -100.0% | -0.58% | – |
| JNJ | Exit | JOHNSON & JOHNSON | $0 | – | -100,000 | -100.0% | -1.84% | – |
| LLY | Exit | LILLY ELI & CO | $0 | – | -88,000 | -100.0% | -3.36% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-05-12
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| UNITEDHEALTH GROUP INC | 40 | Q3 2023 | 4.0% |
| BIOMARIN PHARMACEUTICAL INC | 40 | Q3 2023 | 5.0% |
| ALKERMES PLC | 40 | Q3 2023 | 3.3% |
| LILLY ELI & CO | 39 | Q3 2023 | 5.8% |
| CVS HEALTH CORP | 39 | Q3 2023 | 3.5% |
| INTRA-CELLULAR THERAPIES INC | 39 | Q3 2023 | 2.4% |
| EDWARDS LIFESCIENCES CORP | 39 | Q3 2023 | 1.7% |
| VERTEX PHARMACEUTICALS INC | 38 | Q3 2023 | 4.3% |
| REVANCE THERAPEUTICS INC | 38 | Q3 2023 | 0.9% |
| ABBVIE INC | 37 | Q3 2023 | 4.4% |
View Rhenman & Partners Asset Management AB's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-13 |
| 13F-HR/A | 2023-11-13 |
| 13F-HR | 2023-11-09 |
| 13F-HR | 2023-08-11 |
| 13F-HR | 2023-05-12 |
| 13F-HR | 2023-02-13 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-12 |
| 13F-HR | 2022-05-13 |
| 13F-HR | 2022-02-11 |
View Rhenman & Partners Asset Management AB's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.